Denali Therapeutics Inc. <DNLI.O>: Deutsche Bank Raises Target Price to $35 From $31
DNLI•Related News
Barings provides $86.2 million acquisition loan for Charleston logistics portfolio
MCI•
PN Smart Energy amends registered direct offering price to USD 3 per share
PN•
TWFG, Inc. <TWFG.O>: UBS Raises Target Price to $34 From $30
TWFG•
Microsoft plans to unveil its new Maia 300 AI chip this fall, The Information reports
MSFT•
First Tracks Biotherapeutics Inc <TRAX.O>: UBS raises target price to $65 from $45
TRAX•